CLARUS THERAPEUTICS Trademark

Trademark Overview

On Friday, January 13, 2012, a trademark application was filed for CLARUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CLARUS THERAPEUTICS trademark a serial number of 85515924. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 26, 2024. This trademark is owned by Clarus Therapeutics, Inc.. The CLARUS THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for androgen therapies for men and women deficient in endogenous androgens, testosterone
clarus therapeutics

General Information

Serial Number85515924
Word MarkCLARUS THERAPEUTICS
Filing DateFriday, January 13, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 26, 2024
Registration Number4369447
Registration DateTuesday, July 16, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 19, 2013

Trademark Statements

Description of MarkThe mark consists of the wording "Clarus Therapeutics" with the stylized design of a testosterone molecule consisting of 3 cyclohexane rings and 1 cyclopentane ring. An arrow representing the "male symbol" arises from the side of the cyclopentane ring.
Goods and ServicesPharmaceutical preparations for androgen therapies for men and women deficient in endogenous androgens, testosterone
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "CLARUS" has no meaning in a foreign language.
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateFriday, May 3, 2013
First Use In Commerce DateFriday, May 3, 2013

Trademark Owner History

Party NameTOLMAR, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFORT COLLINS, CO 80526
Party NameClarus Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062
Party NameClarus Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062
Party NameClarus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorthbrook, IL 60062

Trademark Events

Event DateEvent Description
Friday, January 26, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, February 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 16, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, April 13, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, April 13, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 12, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 11, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, July 16, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 16, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, June 9, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, June 6, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 4, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, May 6, 2013USE AMENDMENT FILED
Friday, May 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 6, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, April 16, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 17, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 14, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 17, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 17, 2012LETTER OF SUSPENSION E-MAILED
Wednesday, October 17, 2012SUSPENSION LETTER WRITTEN
Monday, October 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 3, 2012ASSIGNED TO LIE
Tuesday, September 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 20, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 20, 2012NON-FINAL ACTION E-MAILED
Friday, April 20, 2012NON-FINAL ACTION WRITTEN
Friday, April 20, 2012ASSIGNED TO EXAMINER
Friday, January 20, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, January 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 17, 2012NEW APPLICATION ENTERED

Related Keywords

therapeutics clarus endogenous androgens testosterone deficient women preparations androgen therapies pharmaceutical